US Patent Issued to Genentech, Hoffmann-La Roche on Aug. 4 for "Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-Bindol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use" (American, Swiss Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,284, issued on Aug. 4, was assigned to Genentech Inc. (South San Francisco, Calif.) and Hoffmann-La Roche Inc. (Little Falls, N.J.).

"Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-Bindol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use" was invented by Cheol Keun Chung (South San Francisco, Calif.), Jie Xu (San Mateo, Calif.), Hans Iding (Magden, Switzerland), Kyle Clagg (San Francisco), Michael Dalziel (Chicago), Alec Fettes (Basel, Switzerland), Francis Gosselin (San Mateo, Ca...